Price loading...

The 2023-2028 Outlook for Amyloidosis Treatments in China

Price data last checked 108 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Alzheimer's Treatments in China
98% match

The 2023-2028 Outlook for Alzheimer's Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in China
97% match

The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in China

£495.00 14 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China

£495.00 13 Dec 2025
The 2023-2028 Outlook for Sarcopenia Treatments in China
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in China

£495.00 25 Feb 2026
The 2023-2028 Outlook for Pigmentation Disorders Treatments in China
97% match

The 2023-2028 Outlook for Pigmentation Disorders Treatments in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
96% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in China
96% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Amyloidosis Treatments for US Zip Codes

£490.00 24 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Neglected Tropical Disease Treatments in China
96% match

The 2023-2028 Outlook for Neglected Tropical Disease Treatments in China

£495.00 01 Feb 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
96% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China
96% match

The 2023-2028 Outlook for Scleroderma Diagnostics and Therapeutics in China

£495.00 23 Mar 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 31 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in China
96% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in China
96% match

The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in China
96% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Diabetes Treatments in China
96% match

The 2023-2028 Outlook for Diabetes Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in China
96% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in China

£495.00 22 Jan 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in China
96% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China

£495.00 26 Jan 2026
The 2023-2028 Outlook for Vitiligo Treatments in China
96% match

The 2023-2028 Outlook for Vitiligo Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Hepatorenal Syndrome Treatments in China
96% match

The 2023-2028 Outlook for Hepatorenal Syndrome Treatments in China

£495.00 13 Jan 2026